132 related articles for article (PubMed ID: 25826034)
1. [Systemic sclerosis - an update].
Bergmann C; Distler JH
Dtsch Med Wochenschr; 2015 Apr; 140(7):504-7. PubMed ID: 25826034
[No Abstract] [Full Text] [Related]
2. Changing perceptions in pulmonary hypertension.
Gerges C; Lang IM
Lancet Respir Med; 2014 Jan; 2(1):21-3. PubMed ID: 24461891
[No Abstract] [Full Text] [Related]
3. Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Burger CD
Ann Am Thorac Soc; 2015 Jun; 12(6):959. PubMed ID: 26075561
[No Abstract] [Full Text] [Related]
4. Reply: Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
Hill NS; Badesch D; Benza RL; D'Eletto TA; Farber HW; Gomberg-Maitland M; Hassoun PM; Preston I
Ann Am Thorac Soc; 2015 Jun; 12(6):960. PubMed ID: 26075562
[No Abstract] [Full Text] [Related]
5. Novel medical therapies for pulmonary arterial hypertension.
O'Connell C; O'Callaghan DS; Humbert M
Clin Chest Med; 2013 Dec; 34(4):867-80. PubMed ID: 24267310
[TBL] [Abstract][Full Text] [Related]
6. [Pulmonary hypertension--diagnostic and current concepts].
Tröster N; Kovacs G; Olschewski H
MMW Fortschr Med; 2014 Apr; 156(7):49-52; quiz 53. PubMed ID: 24956659
[No Abstract] [Full Text] [Related]
7. Recovery from mitomycin-induced pulmonary arterial hypertension.
Botros L; Van Nieuw Amerongen GP; Vonk Noordegraaf A; Bogaard HJ
Ann Am Thorac Soc; 2014 Mar; 11(3):468-70. PubMed ID: 24673706
[No Abstract] [Full Text] [Related]
8. The use of Macitentan in Fontan circulation: a case report.
Demetriades P; Aziz A; Condliffe R; Bowater SE; Clift PF
BMC Cardiovasc Disord; 2017 May; 17(1):131. PubMed ID: 28532389
[TBL] [Abstract][Full Text] [Related]
9. [Riociguat - a stimulator of soluble guanylate cyclase: a new mode of action helps patients with pulmonary hypertension].
Kreutzkamp B
Med Monatsschr Pharm; 2013 Dec; 36(12):442-7. PubMed ID: 24450268
[No Abstract] [Full Text] [Related]
10. Riociguat approved for pulmonary hypertension.
Traynor K
Am J Health Syst Pharm; 2013 Nov; 70(22):1960. PubMed ID: 24173000
[No Abstract] [Full Text] [Related]
11. Macitentan for the treatment of pulmonary arterial hypertension.
Kholdani CA; Fares WH; Trow TK
Vasc Health Risk Manag; 2014; 10():665-73. PubMed ID: 25473292
[TBL] [Abstract][Full Text] [Related]
12. Macitentan for the treatment of pulmonary arterial hypertension.
DuBrock HM; Channick RN
Expert Rev Respir Med; 2014 Aug; 8(4):393-9. PubMed ID: 24998329
[TBL] [Abstract][Full Text] [Related]
13. First-in-class guanylate cyclase stimulator approved for PAH.
Guha M
Nat Biotechnol; 2013 Dec; 31(12):1064. PubMed ID: 24316627
[No Abstract] [Full Text] [Related]
14. [Targeted therapy of pulmonary arterial hypertension (PAH)].
Klose H; Opitz C; Bremer H; Ewert R; Bonderman D; Rosenkranz S; Seeger W; Schmeißer A; Harbaum L; Buerke M; Ghofrani HA; Borst MM; Leuchte HH; Lange TJ; Behr J; Ulrich S; Lang I; Olschewski H; Gall H; Kabitz HJ; Kleber FX; Held M; Hoeper MM; Grünig E
Dtsch Med Wochenschr; 2014 Dec; 139 Suppl 4():S142-50. PubMed ID: 25489684
[No Abstract] [Full Text] [Related]
15. A new era in the management of pulmonary arterial hypertension related to scleroderma: endothelin receptor antagonism.
Hachulla E; Coghlan JG
Ann Rheum Dis; 2004 Sep; 63(9):1009-14. PubMed ID: 15308510
[TBL] [Abstract][Full Text] [Related]
16. Chronic thromboembolic pulmonary hypertension.
Hoeper MM; Madani MM; Nakanishi N; Meyer B; Cebotari S; Rubin LJ
Lancet Respir Med; 2014 Jul; 2(7):573-82. PubMed ID: 24898750
[TBL] [Abstract][Full Text] [Related]
17. Riociguat for pulmonary hypertension.
Cannon JE; Pepke-Zaba J
Expert Rev Clin Pharmacol; 2014 May; 7(3):259-70. PubMed ID: 24580082
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary arterial hypertension--a rare form of pulmonary hypertension].
Schenk M
Dtsch Med Wochenschr; 2010 May; 135(21):p21. PubMed ID: 20509110
[No Abstract] [Full Text] [Related]
19. Soluble guanylate cyclase stimulation: an emerging option in pulmonary hypertension therapy.
Ghofrani HA; Grimminger F
Eur Respir Rev; 2009 Mar; 18(111):35-41. PubMed ID: 20956121
[TBL] [Abstract][Full Text] [Related]
20. Bosentan increases serum IL-12 levels in systemic sclerosis patients with pulmonary arterial hypertension.
Hamaguchi Y; Fujimoto M; Hasegawa M; Matsushita T; Takehara K
J Dermatol Sci; 2009 Jul; 55(1):66-7. PubMed ID: 19342201
[No Abstract] [Full Text] [Related]
[Next] [New Search]
